Loss of function mutations in ANGPTL4 and genetic variations in PLTP that attenuate its plasma activity have been associated with an attenuated risk of coronary artery disease, emphasizing the relevance of ANGTP4- and PLTP-mediated processes on the development of atherosclerosis [33, 34]. This evidence concerns the gene ANGPTL4 and atherosclerosis.